Estimation of haemopoietic progenitor cells in peripheral blood by the Advia 120 and BD vantage flow cytometer: A direct comparison for the prediction of adequate collections

Clinical and Laboratory Haematology

Volumn 27, Issue 5, 2005, Pages 287-291

  Greenfield, Hayley M ^a,b   Sweeney, D A ^a   Newton, R K ^a   Leather, A ^a   Murray, J ^a   Angelica, R ^a   Swindell, R ^a   Chang, J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Advia 120 automated analyser; Apheresis timing; CD34+ cells; Haemopoietic progenitor cells; Peripheral blood stem cell mobilization

Indexed keywords

BLEOMYCIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MYELOABLATIVE AGENT; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TIOGUANINE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOANALYZER; BLOOD; CANCER CHEMOTHERAPY; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTILITY; COMPARATIVE STUDY; CORRELATION COEFFICIENT; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

ANTIGENS, CD34; AREA UNDER CURVE; BLOOD COMPONENT REMOVAL; CELL COUNT; FLOW CYTOMETRY; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; PRACTICE GUIDELINES;

EID: 26044482252     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00712.x     Document Type: Article

References (14)

1. + progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. British Journal of Haematology 93, 940-942.
2. Attal M., Harousseau J.L., Stoppa A.M., Sotto J.J., Fuzibet J.G., Rossi J.F., Casassus P., Maisonneuve H., Facon T., Ifrah N., Payen C. & Bataille R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. New England Journal of Medicine 335, 91-97.
3. Bononi A., Lanza F., Dabusti M., Gusella M., Gilli G., Menon D., Toso S., Crepaldi G., Marenda B., Abbasciano V. & Ferrazzi E. (2001) Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapy. Cytometry 46, 92-97.
4. Elliott C., Samson D.M., Armitage S., Lyttleton M.P., McGuigan D., Hargreaves R., Giles C., Abrahamson G., Abboudi Z., Brennan M. & Kanfer E.J. (1996) When to harvest peripheral blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. Journal of Clinical Oncology 14, 970-973.
5. Grigg A.P., Roberts A.W., Raunow H., Houghton S., Layton J.E., Boyd A.W., McGrath K.M. & Maher D. (1995) Optimising dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86, 4437-4445.
6. Mink S.A. & Armitage J.O. (2001) High dose therapy in lymphomas: a Review of the current status of allogenic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma. The Oncologist 6, 247-256.
7. Möhle R., Murea S., Pförsich M., Witt B. & Haas R. (1996) Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood. Vox Sanguinis 71, 90-96.
8. Pettengell R., Testa N.G., Swindell R., Crowther D. & Dexter M. (1993) Transplantation potential of haematopoietic cells released into the circulation during routine chemotherapy for non-hodgkin's lymphoma. Blood 82, 2239-2248.
9. Pollard Y., Watts M.J., Grant D., Chavda N., Linch D.C. & Machin S.J. (1999) Use of the haematopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. British Journal of Haematology 106, 538-544.
10. + cells predicts the number of haematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplantation 17, 509-515.
11. Sutherland D.R., Anderson L., Keeney M., Nayar R. & Chin-Yee I. (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. Journal of Hematotherapy 5, 213-226.
12. Vogel W., Kopp H.G., Kanz L. & Einsele H. (2002) Correlations between hematopoetic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens. Journal of Cancer Research and Clinical Oncology, 128, 380-384.
13. Watts M.J., Sullivan A.M., Jamieson E., Pearce R., Fielding A., Devereux S., Goldstone A.H. & Linch D.C. (1997) Progenitor-cell mobilization after low dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. Journal of Clinical Oncology, 15, 535-546.
14. Yu J., Leisenring W., Bensinger W.I., Holmberg L.A. & Rowley S.D. (1999) The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 39, 442-450.